CRISPR dependency screening confirmed that AP1AR moderately contributes to the fitness of lung-cancer cells, implying a non-redundant role in growth maintenance, and these interpretations are supported by the robustness and cross-study concordance of modern CRISPR dependency resources. The gene discussed is AP1AR; the disease is lung carcinoma.